Stavudine (d4T)

DRUG2 trials

Sponsors

Columbia University, Boehringer Ingelheim

Conditions

HIV InfectionsHIV/AIDS

Phase 2

Tipranavir Dose-response Study Using a Prototype Self-emulsifying Drug Delivery System (SEDDS) Formulation in Treatment-naive HIV-1 Infected Patients Report on the Post-study Option, a Treatment of Triple Therapy With Delavirdine, ZDV and 3TC Without Tipranavir

CompletedNCT02249130

Boehringer IngelheimHIV Infections

Start: 1999-03-31Updated: 2014-09-25

Phase 3

Treatment Options for Protease Inhibitor-exposed Children

CompletedNCT01146873

Columbia UniversityHIV/AIDS, HIV Infections

Start: 2010-07-31End: 2014-12-31Updated: 2017-03-13

Related Papers

Switching to Efavirenz Versus Remaining on Ritonavir-boosted Lopinavir in Human Immunodeficiency Virus-infected Children Exposed to Nevirapine: Long-term Outcomes of a Randomized Trial

Clinical Infectious Diseases2017-04-1129 citations

Efavirenz-Based Antiretroviral Therapy Among Nevirapine-Exposed HIV-Infected Children in South Africa

JAMA2015-11-0341 citations